Omni Health Inc (OMHE)

[goodibag]

OMHE_NON_PRESCRIPTION_CBD_MEDs_Alredy_in_use_By_Doctors_FDA_will_Approve_PRESCRIPTION_Meds_in_2018


12/05/2017 MMJ Medicine Development & FDA Approval Plan News - Read Here

Simultaneous to the FDA application for this new drug, the Company will commence by manufacturing OTC analgesic creams and ointments containing CBD with rapid absorption and optimal bioavailability profiles. Given the potency of these analgesics, they will be marketed and distributed exclusively to doctors’ offices, clinics, and hospitals to ensure appropriate patient support and product usage. As per the current schedule, it’s anticipated they this product will be introduced to the North American market during Q3 2018. Based on current market trends and competitor analysis, Omni Health projects generating a recurring annual revenue exceeding $7 Million.

OMHE PPS is heading to $1